Cytokine release syndrome in cancer immunotherapy with chimeric antigen receptor engineered T cells
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference72 articles.
1. Treating B-cell cancer with T cells expressing anti-CD19 chimeric antigen receptors;Kochenderfer;Nat. Rev. Clin. Oncol.,2013
2. Adoptive T-cell therapy of B-cell malignancies: conventional and physiological chimeric antigen receptors;Liu;Cancer Lett.,2012
3. Chimeric antigen receptor-engineered T cells for cancer immunotherapy: progress and challenges;Han;J. Hematol. Oncol.,2013
4. CD20-specific adoptive immunotherapy for lymphoma using a chimeric antigen receptor with both CD28 and 4-1BB domains: pilot clinical trial results;Till;Blood,2012
5. T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia;Kalos;Sci. Trans. Med.,2011
Cited by 121 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Bayesian network analysis of risk classification strategies in the regulation of cellular products;Artificial Intelligence in Medicine;2024-09
2. Systemic toxicity of CAR-T therapy and potential monitoring indicators for toxicity prevention;Frontiers in Immunology;2024-08-26
3. Obstacles to global implementation of CAR T cell therapy in myeloma and lymphoma;Frontiers in Oncology;2024-07-19
4. CAR-T cell-derived exosomes: a new perspective for cancer therapy;Stem Cell Research & Therapy;2024-06-18
5. The critical impacts of cytokine storms in respiratory disorders;Heliyon;2024-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3